These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34649475)

  • 1. Improving the data quality of spontaneous ADR reports: a practical example from Malta.
    Zuccarelli M; Micallef B; Butler D; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2022 Feb; 21(2):253-268. PubMed ID: 34649475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
    Curtolo E; Micallef B; Szijj JV; Serracino-Inglott A; Borg JJ
    Int J Risk Saf Med; 2024; 35(3):271-286. PubMed ID: 38820023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a national combined reporting form for adverse drug reactions and medication errors.
    Tanti A; Serracino-Inglott A; Borg JJ
    East Mediterr Health J; 2015 Jun; 21(4):246-55. PubMed ID: 26077519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
    Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
    Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
    Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
    Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
    Rehan HS; Chopra D; Holani SN; Mishra R
    Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China.
    Li B; Jiang L; Liao L; Chen Y; Xu Z; Wu N; Chen H; Wu P; Liu T
    Eur J Clin Pharmacol; 2024 Mar; 80(3):383-393. PubMed ID: 38151504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions' reporting in a Mexican hospital.
    Valdez-Ramírez LA; Serrano-Medina A; Cornejo-Bravo JM
    Int J Pharm Pract; 2020 Dec; 28(6):660-662. PubMed ID: 32476179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.
    Schutte T; Tichelaar J; Reumerman MO; van Eekeren R; Rolfes L; van Puijenbroek EP; Richir MC; van Agtmael MA
    Drug Saf; 2017 May; 40(5):409-418. PubMed ID: 28120270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
    Johansson ML; Hägg S; Wallerstedt SM
    BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.